Psychotherapy Effects on Reward Processing in PTSD

Description

The purpose of this study is to identify how trauma-focused psychotherapy changes the function of brain circuitry in posttraumatic stress disorder (PTSD) and how this mediates improvements in the diminished ability to experience positive emotions following a traumatic or extremely stressful life event. In this instance, the investigators will be using cognitive processing therapy (CPT), a widely-utilized and evidence-based treatment for PTSD.

Conditions

Post Traumatic Stress Disorder, Diminished Pleasure, Anhedonia, PTSD, Chronic PTSD, Chronic Post-Traumatic Stress Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to identify how trauma-focused psychotherapy changes the function of brain circuitry in posttraumatic stress disorder (PTSD) and how this mediates improvements in the diminished ability to experience positive emotions following a traumatic or extremely stressful life event. In this instance, the investigators will be using cognitive processing therapy (CPT), a widely-utilized and evidence-based treatment for PTSD.

The Effects of Trauma-focused Psychotherapy on Reward Circuitry Function and Information Encoding

Psychotherapy Effects on Reward Processing in PTSD

Condition
Post Traumatic Stress Disorder
Intervention / Treatment

-

Contacts and Locations

Austin

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin, Texas, United States, 78712

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * English as primary language, and comprehension suitable to understand experimenter instructions.
  • * Current and chronic syndromic PTSD, defined as being exposed to a DSM-5 Criterion A traumatic event, with the presence DSM-5 qualifying PTSD symptoms for at least 3 months, as assessed by the Clinician-Administered PTSD Scale for DSM-5.
  • * Able and willing to undergo functional magnetic resonance imaging (fMRI).
  • * Willingness to participate in repeated assessments and as part of a delayed treatment group.
  • * Evidence of current or prior history of psychosis or bipolar disorder as evidenced by self-report or clinical interview.
  • * Active substance dependence within the past 6 months as evidenced by clinical interview.
  • * Current regular psychiatric medication use (i.e. antidepressants), except for as-needed benzodiazepine or opiate medication no more than three times per week, on average, or for short-duration stimulant medication for attention deficit hyperactivity disorder that can be skipped within 24 hours of study visits.
  • * A recent (\<6 months) suicide attempt or current active ideation with intent.
  • * Unremovable ferrous metal in body.
  • * History of neurological disorder, stroke, seizures/convulsions (except febrile seizures in childhood), epilepsy, brain surgery, electroconvulsive or radiation treatment, brain hemorrhage or tumor, or thyroid disorder.
  • * Anyone who is pregnant or trying to become pregnant.
  • * Current or past year (\> 3 sessions), psychotherapy with a prominent exposure or cognitive restructuring component.
  • * Previous or current (es)ketamine treatment and/ or brain stimulation/neuromodulation treatment.
  • * Other ongoing treatment that is likely to confound experimental effects.
  • * Previous penetrating head injury/traumatic brain injury. Mild-to-moderate traumatic brain injury without penetrating injury is allowable.

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Texas at Austin,

Gregory A Fonzo, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas at Austin

Study Record Dates

2029-05-01